Abstract:Salmonella enterica serovar Typhimurium (S. Typhimurium), a foodborne pathogen that poses significant public health risks to humans and animals, presents a formidable challenge due to its antibiotic resistance. This study explores the potential of Lactobacillus acidophilus (L. acidophilus 1.3251) probiotics as an alternative strategy to combat antibiotic resistance associated with S. Typhimurium infection. In this investigation, twenty-four BALB/c mice were assigned to four groups: a non-infected, non-treated group (CNG); an infected, non-treated group (CPG); a group fed with L. acidophilus but not infected (LAG); and a group fed with L. acidophilus and challenged with Salmonella (LAST). The results revealed a reduction in Salmonella levels in the feces of mice, along with restored weight and improved overall health in the LAST compared to the CPG. The feeding of L. acidophilus was found to downregulate pro-inflammatory cytokine mRNA induced by Salmonella while upregulating anti-inflammatory cytokines. Additionally, it influenced the expression of mRNA transcript, encoding tight junction protein, oxidative stress-induced enzymes, and apoptosis-related mRNA expression. Furthermore, the LEfSe analysis demonstrated a significant shift in the abundance of critical commensal genera in the LAST, essential for maintaining gut homeostasis, metabolic reactions, anti-inflammatory responses, and butyrate production. Transcriptomic analysis revealed 2173 upregulated and 506 downregulated differentially expressed genes (DEGs) in the LAST vs. the CPG. Functional analysis of these DEGs highlighted their involvement in immunity, metabolism, and cellular development. Kyoto Encyclopedia of Genes and Genome (KEGG) pathway analysis indicated their role in tumor necrosis factor (TNF), mitogen-activated protein kinase (MAPK), chemokine, Forkhead box O (FOXO), and transforming growth factor (TGF-β) signaling pathway. Moreover, the fecal metabolomic analysis identified 929 differential metabolites, with enrichment observed in valine, leucine, isoleucine, taurine, glycine, and other metabolites. These findings suggest that supplementation with L. acidophilus promotes the growth of beneficial commensal genera while mitigating Salmonella-induced intestinal disruption by modulating immunity, gut homeostasis, gut barrier integrity, and metabolism.

Preventive of Lacticaseibacillus Casei WLCA02 Against Salmonella Typhimurium Infection Via Strengthening the Intestinal Barrier and Activating the Macrophages

Lacticaseibacillus Rhamnosus Alleviates Intestinal Inflammation and Promotes Microbiota-Mediated Protection Against Salmonella Fatal Infections.

Cytoprotective Effects of <i>Lactobacilli</i> on Mouse Epithelial Cells during <i>Salmonella</i> Infection

The Prophylactic Protection of Salmonella Typhimurium Infection by Lentilactobacillus Buchneri GX0328-6 in Mice

Prevention of enteric bacterial infections and modulation of gut microbiota with conjugated linoleic acids producing Lactobacillus in mice

Lactiplantibacillus Plantarum 1201 Inhibits Intestinal Infection of Salmonella Enterica Subsp. Enterica Serovar Typhimurium Strain ATCC 13311 in Mice with High-Fat Diet.

Limiting the pathogenesis of Salmonella Typhimurium with berry phenolic extracts and linoleic acid overproducing Lactobacillus casei

The Intervention Effects of Lactobacillus Casei LC2W on Escherichia Coli O157:H7-induced Mouse Colitis

Microencapsulated Limosilactobacillus reuteri Encoding Lactoferricin-Lactoferrampin Targeted Intestine against Salmonella typhimurium Infection

Lacticaseibacillus Rhamnosus P118 Enhances Host Tolerance to Salmonella Infection by Promoting Microbe-Derived Indole Metabolites

Deciphering Microbiome, Transcriptome, and Metabolic Interactions in the Presence of Probiotic Lactobacillus acidophilus against Salmonella Typhimurium in a Murine Model

Molecular Mechanisms of Intestinal Protection by Levilactobacillus brevis 23017 against Salmonella typhimurium C7731-Induced Damage: Role of Nrf2

Bacillus velezensis HBXN2020 alleviates Salmonella Typhimurium infection in mice by improving intestinal barrier integrity and reducing inflammation

Lactobacillus johnsonii L531 Alleviates the Damage Caused by Salmonella Typhimurium via Inhibiting TLR4, NF-κB, and NLRP3 Inflammasome Signaling Pathways

Novel Synergistic Probiotic Intervention: Transcriptomic and Metabolomic Analysis Reveals Ameliorative Effects on Immunity, Gut Barrier, and Metabolism of Mice during Salmonella typhimurium Infection

<i>Lactobacillus johnsonii</i> L531 Alleviates the Damage Caused by <i>Salmonella</i> Typhimurium via Inhibiting TLR4, NF-B, and NLRP3 Inflammasome Signaling Pathways

Cytoprotective Effects of Lactobacilli on Mouse Epithelial Cells during Salmonella Infection

Protective function of surface layer protein from Lactobacillus casei fb05 against intestinal pathogens in vitro

Lactobacillus crispatus 7-4 Mitigates Salmonella typhimurium-Induced Enteritis via the γ‐Glutamylcysteine-Mediated Nrf2 Pathway

A Phage Cocktail Combined with the Enteric Probiotic Lactobacillus Reuteri Ameliorated Mouse Colitis Caused by S. Typhimurium

Lactobacillus plantarum RS-09 Induces M1-Type Macrophage Immunity Against Salmonella Typhimurium Challenge via the TLR2/NF-κB Signalling Pathway